Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Non Operating Income (2022 - 2025)

Historic Non Operating Income for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$1.2 million.

  • PAVmed's Non Operating Income changed N/A to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year change of. This contributed to the annual value of $72.9 million for FY2024, which is 79654.18% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Non Operating Income is -$1.2 million.
  • PAVmed's Non Operating Income's 5-year high stood at $24.1 million during Q1 2025, with a 5-year trough of -$7.6 million in Q2 2025.
  • For the 4-year period, PAVmed's Non Operating Income averaged around -$478785.7, with its median value being -$1.3 million (2023).
  • As far as peak fluctuations go, PAVmed's Non Operating Income crashed by 9075000.0% in 2023, and later surged by 71746.34% in 2024.
  • Quarter analysis of 4 years shows PAVmed's Non Operating Income stood at $29000.0 in 2022, then plummeted by 3634.48% to -$1.0 million in 2023, then skyrocketed by 717.46% to $6.3 million in 2024, then tumbled by 118.44% to -$1.2 million in 2025.
  • Its Non Operating Income was -$1.2 million in Q3 2025, compared to -$7.6 million in Q2 2025 and $24.1 million in Q1 2025.